BIOMÉRIEUX LAUNCHES PREVI ISOLA WITH LABTECH’S MICROSTREAK
December 14th 2008 22:46
Wednesday December 10, 2008
Daily news on ASX-listed biotechnology companies
* ASX UP, BIOTECHS EVEN: POLARTECH UP 25%, ALCHEMIA DOWN 13%
* AGENIX SETTLES CHINA DEAL
* POLARTECHNICS RENEWS TRUSCREEN DELIVERY TO CHINA, INDIA
* BIOMÉRIEUX LAUNCHES PREVI ISOLA WITH LABTECH’S MICROSTREAK
* GREIFSWALD UNI’S PROTEOMICS UNIT BUYS FLUOROTECHNICS’ GELS
* VICTORIA GOVERNMENT’S $5m FOR MONASH ELECTRON MICROSCOPY
* JP MORGAN CHASE TAKES 7% OF QRX PHARMA
* PROGEN CFO LINTON BURNS DEPARTS BIOTECH
* MEDICAL THERAPIES APPOINTS DR JULIA HILL COO; REPLACES CO SEC
* PROF IAN FRAZER QUITS OBJ’S SCIENTIFIC BOARD
* SAFETY MEDICAL EXTENDS TRADING HALT TO SUSPENSION
To read all these articles in full, subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
LABTECH SYSTEMS
Labtech says Biomérieux’s Previ Isola, incorporating Labtech’s Microstreak technology, has been launched with the first commercial sales made to clinical laboratories.
Labtech said the Previ Isola was the first instrument to incorporate the Microstreak technology.
This company said the automated agar plate streaker performed one of the core tasks of diagnostic microbiology and had the capacity to offer significant time, space and cost savings to laboratory operators.
In the current trend of laboratory concentration, there was strong demand for automation that can standardize processes and provide traceability, timesaving and optimized workflow, as well as improved safety, Labtech said.
The company said Previ Isola offered staff “the opportunity to use their time in more valuable activities that relate to patient care”.
Labtech said the commercial launch was beginning in mid-sized clinical microbiology laboratories in the US and Western Europe.
Labtech will receive royalty payments on sales of the patented disposable applicators that effect the agar plate streaking.
Labtech chief executive officer Lusia Guthrie said her company was “delighted to see the full commercial launch of the first product using our Microstreak technology”.
Labtech was up 2.5 cents or 19.23 percent to 15.5 cents.
To read all these articles in full, subscribe to Biotech Daily at the link above or at www.biotechdaily.com.au
| 29 |
| Vote |
Add To: 
subscribe to this blog